Navigation Links
World's tiniest preemies are growing up and doing fine
Date:12/11/2011

MAYWOOD, Il. -- In 1989, Madeline Mann became the world's smallest surviving baby after she was born at Loyola University Medical Center. She weighed 280 g. (9.9 oz.) -- about the size of an iPhone.

In 2004. Rumaisa Rahmam set a Guinness World Record after she was born at Loyola, weighing 260 g. (9.2 oz.).

Remarkably, Madeline and Rumaisa both have normal motor and language development, Loyola physicians wrote in a case report in Pediatrics, the official journal of the American Academy of Pediatrics. The article was published online Dec. 12.

Rumaisa remains the world's smallest surviving baby, and Madeline now is the world's fourth smallest surviving baby, according to a registry kept by the University of Iowa Children's Hospital. Rumaisa and Madeline are the smallest and second smallest surviving babies born in the United States. And Rumaisa and her twin sister, Hiba, are the world's smallest surviving twins. (Hiba weighed 1 pound, 5 oz. at birth).

Of the 85 smallest surviving babies in the United States, three were born at Loyola and five others were cared for by physicians trained at Loyola.

Lead author Jonathan Muraskas, MD, and colleagues caution that successful outcomes such as Madeline and Rumaisa are not necessarily typical. Many extremely low-birth-weight preemies either do not survive or grow up with severe, lifelong disabilities such as cerebral palsy, mental retardation and blindness.

Comparing other micropreemies with Madeline and Rumaisa could "propagate false expectations for families, caregivers and the medico-legal community alike," Muraskas and colleagues wrote.

Madeline and Rumaisa had several advantages. Female preemies tend to do better than males. They had relatively long gestational ages for their birthweights. And their mothers were given steroids before birth, which helped their lungs and brains mature more quickly.

During their pregnancies, Madeline's and Rumaisa's mothers experienced preeclampsia (pregnancy-induced high blood pressure). There was decreased blood flow through the placenta, which restricted the babies' growth. Madeline was born at 26 weeks, six days, and Rumaisa was born at 25 weeks, six days. Under normal conditions, it would take a fetus just 18 weeks to reach their birthweights.

Madeline spent 122 days in Loyola's neonatal intensive care unit, and Rumaisa spent 142 days. They each have met developmental milestones at appropriate ages. Rumaisa, 7, is a first grader and Madeline, 22, is an honor student at Augustana College in Rock Island, Il. But they both remain small for their ages.

Advances in neonatal care have allowed the resuscitation and survival of smaller and smaller newborns, Muraskas and colleagues wrote. They suggest that at the threshold of viability, three critical factors should be considered: gestational age, steroid treatment before birth and female gender.

"With Japan lowering its limit of viability to 22 weeks and public fascination with micropreemies, how small is too small? The medical, ethical and economic issues will continue to be vigorously debated."
'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. Gunther von Hagens BODY WORLDS of Animals Opening March 19 at the Neunkirchen Zoo
2. Anthropologist: Body Worlds visitors confront bodies but not death
3. Losing Weight, Keeping It Off Can Be Two Different Worlds
4. Probiotics Beneficial for Tiniest Preemies
5. Tiniest Newborns With Down Syndrome Face Other Health Risks
6. In U.S., Obesity Afflicts Even Some of the Tiniest Tots
7. Youngest Preemies Survival Rate Unchanged
8. DHA Supplements for Mom Good for Preemies
9. For Preemies, Better Use of Oxygen Improves Survival
10. Nitric Oxide Doesnt Seem to Help Preemies Lungs: Report
11. New Tool Aims to Predict Problems in Preemies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), ... labor and delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding ... the hospital and decide to donate. , “Women’s Hospital at Renaissance has been ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early detection and elimination ... safety and minimize the cost of development. In this webinar, sponsored by Molecular ... lines and for cardiac toxicity using induced pluripotent stem cells (iPSCs). , In ...
(Date:4/28/2017)... ... ... Bill Howe started his sewer and drain company in 1980 focusing heavily ... team, the Bill Howe brand was born and they began cultivating their mission to ... the San Diego community in which they worked, lived and were raising their daughters. ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... of ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled ... wearable activity and sleep monitoring solutions for the global scientific community. The company’s ...
(Date:4/28/2017)... ... 2017 , ... Intellitec Solutions announced the publication of a ... Dynamics GP solution that integrates to their PointClickCare EHR software package. With the ... Brooke Grove now has the capability to achieve its goal for a comprehensive ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), ... it will be participating in the Deutsche Bank Securities ... in Boston, Massachusetts on Wednesday, ... a.m. Eastern Time. A live webcast of ... Relations website at http://investor.zimmerbiomet.com .  The webcast will ...
(Date:4/20/2017)... April 20, 2017 Research and Markets has ... Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of ... ... delivery technologies will rise from USD 20 Billion in 2015 to ... Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market ...
(Date:4/20/2017)... 20, 2017  AbbVie (NYSE: ABBV), a global ... of chronic hepatitis C virus (HCV) infected patients ... and compensated cirrhosis (Child-Pugh A) achieved sustained virologic ... with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). ... following 12 weeks of G/P treatment without ribavirin. ...
Breaking Medicine Technology: